Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells

Journal of Immunological Methods

Volumn 204, Issue 1, 1997, Pages 77-87

  Norderhaug, Lars ^a   Olafsen, Tove ^b   Michaelsen, Terje E ^a   Sandlie, Inger ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

antibody engineering; expression vector; immunoglobulin expression; polymerase chain reaction

Indexed keywords

CHIMERIC ANTIBODY; RECOMBINANT PROTEIN;

ARTICLE; GENETIC ENGINEERING; HYBRIDOMA; IMMUNOGLOBULIN GENE; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030972407     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00034-3     Document Type: Article

References (52)

1. Bebbington, C.R., Renner, G., Thomson, S., King, D., Abrams, D., Yarranton, G.T., 1992. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology 10, 169.
2. Brekke, O.H., Michaelsen, T.E., Sandlie, I., 1995. The structural requirements for complement activation by IgG: does it hinge on the hinge?. Immunol. Today 16, 85.
3. Borrebaeck, C.A., Danielsson, L., Møller, S.A., 1988. Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 85, 3995.
4. Brüggemann, M., Williams, G.T., Bindon, C.I., Clark, M.R., Walker, M.R., Jefferis, R., Waldmann, H., Neuberger, M.S., 1987. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 166, 1351.
5. Bruland, O., Fodstad, O., Funderud, S., Pihl, A., 1986. New monoclonal antibodies specific for human sarcomas. Int. J. Cancer. 38, 27.
6. Bruland, O., Fodstad, O., Skretting, A., Pihl, A., 1987. Selective localization of two radiolabeled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts. Br. J. Cancer. 56, 21.
7. Bruland, O.S., Fodstad, O., Stenwig, A.E., Pihl, A., 1988. Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen. Cancer. Res. 48, 5302.
8. Bruland, O.S., Fodstad, O., Aas, M., Solheim, O.P., Hoie, J., Skretting, A., Winderen, M., Michaelsen, T., Pihl, A., 1994. Immunoscintigraphy of bone sarcomas results in 5 patients. Eur. J. Cancer 30A, 1484.
9. Burton, D.R., 1991. Human and mouse monoclonal antibodies by repertoire cloning. Trends Biotechnol. 9, 169.
10. Chapman, B.S., Thayer, R.M., Vincent, K.A., Haigwood, N.L., 1991. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acid Res. 19 (14), 3979.
11. Chothia, C., Lesk, A.M., Tramantano, A., Levitt, M., Smith-Gill, S.J., Air, G., Sheriff, S., Padlan, E.A., Davies, D., Tulip, W.R., Colman, P.M., Spinelli, S., Alzari, P.M., Poljak, R.J., 1989. Conformations of immunoglobulin hypervariable regions. Nature 342, 877.
12. Coloma, M.J., Larrick, J.W., Ayala, M., Gavilondo-Cowley, J.V., 1991. Primer design for the cloning of immunoglobulin heavy-chain leader-variable regions from mouse hybridoma cells using the PCR. Biotechniques 11, 152.
13. Coloma, M.J., Hastings, A., Wims, L.A., Morrison, S.L., 1992. Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J. Immunol. Methods 152, 89.
14. Evans, M.J., Hartman, S.L., Wolff, D.W., Rollins, S.A., Squinto, S.P., 1995. Rapid expression of an anti-human C5 chimeric Fab utilizing a vector that replicates in COS and 293 cells. J. Immunol. Methods 184, 123.
15. Foote, J., Winter, G., 1992. Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224, 487.
16. Gillies, S.D., Lo, K.M., Wesolowski, J., 1989. High-level expression of chimeric antibodies using adapted cDNA variable region cassettes. J. Immunol. Methods 125, 191.
17. Gluzman, Y., 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23, 175.
18. Haines, D.M., Bruland, Ø.S., 1989. Immunohistochemical detection of osteosarcoma-associated antigen in canine osteosarcoma. Anticancer Res. 9, 903.
19. Huse, W.D., Sastry, L.S., Iverson, S.A., Kang, A.S., Alting-Mees, M., Burton, D.R., Benkovic, S.J., Lerner, R.A., 1989. Generation of large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 246, 1275.
20. Johnson, G., Wu, T.T., Kabat, E.A., 1995. SEQHUNT, a program to search aligned nucleotide and amino acid sequences. In: Paul, S. (Ed.), Antibody Engineering and Catalytic Antibodies, Humana Press, p. 1.
21. Johnson, G., Kabat, E.A., Wu, T.T., 1996. Kabat database of sequences of proteins of immunological interest. In: Weir, D.M. (Ed.), Handbook of Experimental Immunology I. Immunochemistry, Blackwell, Oxford, chapter 5.
22. Kabat, E.A., Wu, T.T., Perry, H.M., Gottesman K.S., Foeller, C., 1991. Sequences of Proteins of Immunological Interest, 5th ed. Public Health Service, NIH, Washington DC.
23. Kanda, H., Mori, K., Koga, H., Taniguchi, K., Kobayashi, H., Sakahara, H., Konishi, J., Endo, K., Watanabe, T., 1994. Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector. Hybridoma 13 (5), 359.
24. Kettleborough, C.A., Saldanha, J., Ansell, K.H., Bendig, M.M., 1993. Optimization of primers for cloning libraries of mouse immunoglobulin genes using the polymerase chain reaction. Eur. J. Immunol. 23, 206.
25. Kunkel, T.A., 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82, 488.
26. Köhler, G., Milstein, C., 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495.
27. Kozak, M., 1981. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res. 9, 5233.
28. Larrick, J.W., Danielsson, L., Brenner, C.A., Wallace, E.F., Abrahamson, M., Fry, K.E., Borrebaeck, C.A., 1989. Polymerase chain reaction using mixed primers: cloning of human monoclonal antibody variable region genes from single hybridoma cells. Biotechnology 7, 934.
29. McCafferty, J., Griffiths, A.D., Winter, G., Chiswell, D.J., 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552.
30. Michaelsen, T.E., Aase, A., Westby, C., Sandlie, I., 1990. Enhancement of complement activation and cytolysis of human Igy3 by deletion of hinge exons. Scand. J. Immunol. 32, 517.
31. Morrison, S.L., 1985. Transfectomas provide novel chimeric antibodies. Science 229, 1202.
32. Neuberger, M.S., 1983. Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. EMBO J. 2, 1373.
33. Neuberger, M.S., Williams, G.T., Mitchell, E.B., Jouhal, S.S., Flanagan, J.G., Rabbitts, T.H., 1985. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 314, 268.
34. Neuberger, M.S., Williams, G.T., 1988. The intron requirement for immunoglobulin gene expression is dependent upon the promoter. Nucleic Acids Res. 16, 6713.
35. Olafsen, T., Bruland, Ø.S., Zalutsky, M.R., Sandlie, I., 1995. Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: Location of lysine residues and implications for radiolabeling. Nucl. Med. Biol. 22, 765.
36. Orlandi, R., Gussow, D.H., Jones, P.T., Winter, G., 1989. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86, 3833.
37. Owens, R.J., Young, R.J., 1994. The genetic engineering of monoclonal antibodies. J. Immunol. Methods 168, 149.
38. Pound, J.D., Lund, J., Jefferis, R., 1993. Aglycosylated chimaeric human Igγ3 can trigger the human phagocyte respiratory burst. Mol. Immunol. 30, 233.
39. Queen, C., Schneider, W.P., Selick, H.E., Payne, P.W., Landolfi, N.F., Duncan, J.F., Avdalovic, N.M., Levitt, M., Junghans, R.P., Waldmann, T.A., 1989. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 86, 10029.
40. Riechmann, L., Clark, M., Waldmann, H., Winter, G., 1988a. Reshaping human antibodies for therapy. Nature 332, 323.
41. Riechmann, L., Foote, J., Winter, G., 1988b. Expression of an antibody Fv fragment in myeloma cells. J. Mol. Biol 203, 825.
42. Ridder, R., Geisse, S., Kleuser, B., Kawalleck, P., Gram, H., 1995. A COS-cell-based system for rapid production and quantification of scFV::IgCK antibody fragments. Gene 166, 273.
43. Sandlie, I., Aase, A., Westby, C., Michaelsen, T.E., 1989. C1q binding to chimeric monoclonal Igγ3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids. Eur. J. Immunol. 19, 1599.
44. Sastry, L., Alting-Mees, M., Huse, W.D., Short, J.M., Sorge, J.A., Hay, B.N., Janda, K.D., Benkovic, S.J., Lerner, R.A., 1989. Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: construction of a heavy chain variable region-specific cDNA library. Proc. Natl. Acad. Sci. USA 86, 5728.
45. Shitara, K., Nakamura, K., Tokutake-Tanaka, Y., Fukushima, M., Hanai, N., 1994. A new vector for the high level expression of chimeric antibodies in myeloma cells. J. Immunol. Methods 167, 271.
46. Shopes, B., 1992. A genetically engineered human IgG mutant with enhanced cytolytic activity. J. Immunol. 148, 2918.
47. Tao, M.H., Morrison, S.L., 1989. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143, 2595.
48. von Heijne, G., 1985. Signal sequences, the limits of variation. J. Mol. Biol. 184, 99.
49. Walls, M.A., Hsiao, K.C., Harris, L.J., 1993. Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions. Nucleic Acids Res. 21, 2921.
50. Winter, G., Milstein, C., 1991. Man-made antibodies. Nature 349, 293.
51. Winter, G., Griffiths, A.D., Hawkins, R.E., Hoogenboom, H.R., 1994. Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433.
52. Yokota, T., Milenic, D.E., Whitlow, M., Schlom, J., 1992. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52, 3402.